ModivCare Inc. MODVQ
0.02
0.00
0.00%
as of 1 Apr
- Market cap
- $6.2M
- P/E
- 0.0×
Follow MODVQ
Growth Flags
show if company had growth for consecutive years
| Older periods | Dec '24 | Mar '25 | Jun '25 | Sep '25 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.06 | 0.01 | 0.02 | 0.00 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
5.61 | (0.23) | (2.02) | (0.05) | |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
0.47 | 0.46 | 0.48 | 0.36 | |
EV/EBITDA |
10.23 | 9.86 | 11.22 | 10.14 | |
EV/Operating CF |
(205.40) | (12.85) | (20.07) | (7.76) | |
EV/FCF |
(38.67) | (10.34) | (14.69) | (6.59) | |
Quick Ratio |
0.75 | 0.75 | 0.75 | 1.52 | |
Current Ratio |
0.79 | 0.80 | 0.80 | 1.64 | |
Net Debt/EBITDA |
34.93 | 50.96 | 52.61 | (4.67) | |
Debt/Assets |
76.21% | 81.18% | 98.06% | 4.40% | |
Debt/Equity |
(32.77) | (15.54) | (3.52) | (0.13) | |
Asset Turnover |
1.63 | 1.60 | 1.76 | 1.75 | |
Operating CF/Net income |
(1.28) | 1.63 | 0.07 | 0.69 | |
Capex/Depreciation |
(0.19) | (0.14) | (0.02) | (0.23) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
10.56% | 12.08% | 10.70% | 12.41% | |
Intangible Assets out of Total Assets |
0.58 | 0.56 | 0.47 | 0.46 | |
Share Based Compensation of Revenue |
0.27% | 0.19% | 2.22% | 0.09% | |
Graham Net Nets |
(7.10) | (65.10) | (27.81) | (473.80) | |
Graham Number |
29.33 | 47.07 | 131.56 | 150.89 | |
Earnings Yield |
(119.51%) | (1,219.70%) | (903.53%) | (16,526.32%) | |
Free Cash Flow Yield |
(20.19%) | (644.45%) | (198.24%) | (5,371.92%) | |
Revenue per Share |
49.35 | 45.41 | 45.95 | 47.20 | |
Operating CF per Share |
2.11 | (5.73) | (1.55) | (3.51) | |
Capex per Share |
(0.38) | (0.28) | (0.46) | (0.43) | |
Free Cash Flow per Share |
1.73 | (6.01) | (2.01) | (3.93) | |
Cash per Share |
7.94 | 8.37 | 8.40 | 8.98 | |
Shareholders Equity per Share |
(2.70) | (6.12) | (27.29) | (32.23) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(2.70) | (6.12) | (27.29) | (32.23) | |
Free Cash Flow |
24.70 | (86.15) | (28.86) | (56.67) | |
Working Capital |
(129.11) | (134.22) | (134.35) | 229.53 | |
Capital Expenditures |
(5.35) | (4.06) | (6.65) | (6.18) | |
Net Current Asset Value |
(1,197.43) | (1,231.37) | (1,245.21) | (1,296.41) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 | |
Net Profit Margin |
(3.34%) | (7.74%) | (46.04%) | (10.76%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
365.98 | 371.95 | 398.09 | 395.35 | |
Average Payables |
69.15 | 56.15 | 69.23 | 70.42 | |
Average Assets |
1,710.80 | 1,720.61 | 1,541.85 | 1,535.66 | |
Average Common Equity |
58.86 | 24.10 | (191.06) | (240.56) |
Columns are period end dates